Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Prostate Cancer

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 34 articles:
HTML format



Single Articles


    May 2025
  1. METSER U, Zukotynski K, Mak V, Langer D, et al
    Erratum for: Effect of (18)F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
    Radiology. 2025;315:e259010.
    PubMed    


    April 2025
  2. WESTPHALEN AC
    Building the Foundation for AI in Prostate Cancer Imaging.
    Radiology. 2025;315:e243352.
    PubMed    


  3. TURKBEY B, Huisman H, Fedorov A, Macura KJ, et al
    Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0.
    Radiology. 2025;315:e240140.
    PubMed     Abstract available


    March 2025
  4. TAKAHASHI T
    Prostate Cancer Screening: Empirical Clinical Practice for 70 Years.
    Radiology. 2025;314:e242184.
    PubMed    


  5. LEE YJ, Moon HW, Choi MH, Eun Jung S, et al
    MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study.
    Radiology. 2025;314:e232788.
    PubMed     Abstract available


  6. HARMATH C
    AI in Prostate Cancer Diagnosis with MRI: A Friend Not a Foe.
    Radiology. 2025;314:e250525.
    PubMed    


    February 2025
  7. STEINHELFER L, Jungmann F, Nickel M, Kaissis G, et al
    Automated CT Measurement of Total Kidney Volume for Predicting Renal Function Decline after (177)Lu Prostate-specific Membrane Antigen-I&T Radioligand Therapy.
    Radiology. 2025;314:e240427.
    PubMed     Abstract available


    January 2025
  8. HUANG H, Mo J, Ding Z, Peng X, et al
    Deep Learning to Simulate Contrast-Enhanced MRI for Evaluating Suspected Prostate Cancer.
    Radiology. 2025;314:e240238.
    PubMed     Abstract available


    December 2024
  9. CORNUD F, de Bie K, van Riel L, Lefevre A, et al
    MRI-directed Micro-US-guided Transperineal Focal Laser Ablation for Localized Prostate Cancer: A 1-year Follow-up Study.
    Radiology. 2024;313:e233371.
    PubMed     Abstract available


    October 2024
  10. YANG DD, Lee LK, Tsui JMG, Leeman JE, et al
    AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer.
    Radiology. 2024;313:e240041.
    PubMed     Abstract available


    September 2024
  11. TAKAHASHI T
    Rationale for MRI-guided Focused Ultrasound Focal Therapy for Prostate Cancer.
    Radiology. 2024;312:e240738.
    PubMed    


    August 2024
  12. JOHNSON PM, Chandarana H
    AI-powered Diagnostics: Transforming Prostate Cancer Diagnosis with MRI.
    Radiology. 2024;312:e241009.
    PubMed    


  13. CAI JC, Nakai H, Kuanar S, Froemming AT, et al
    Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI.
    Radiology. 2024;312:e232635.
    PubMed     Abstract available


  14. CIVELEK AC
    Prostate Cancer: Improved Patient Care in the Age of Advancing Theranostics.
    Radiology. 2024;312:e241564.
    PubMed    


  15. OERTHER B, Nedelcu A, Engel H, Schmucker C, et al
    Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis.
    Radiology. 2024;312:e233337.
    PubMed     Abstract available


  16. KOHLBRENNER R, Wu X, Nguyen HG, Cooperberg MR, et al
    Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma.
    Radiology. 2024;312:e232544.
    PubMed     Abstract available


  17. TAMMISETTI VS, Jacobs MA
    Evidence-based Diagnostic Performance Benchmarks in Prostate MRI: An Unmet Clinical Need.
    Radiology. 2024;312:e241792.
    PubMed    


  18. KUO PH, Morris MJ, Hesterman J, Kendi AT, et al
    Quantitative (68)Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following (177)Lu-PSMA-617 (VISION Trial).
    Radiology. 2024;312:e233460.
    PubMed     Abstract available


    July 2024
  19. GHAI S, Klotz L, Pond GR, Kebabdjian M, et al
    Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer.
    Radiology. 2024;312:e231948.
    PubMed     Abstract available


  20. SCIALPI M, Martorana E
    Apparent Diffusion Coefficient and Biopsy in Detecting Cribriform and Intraductal Carcinoma Prostate Cancer.
    Radiology. 2024;312:e241043.
    PubMed    


    June 2024
  21. SCHIEDA N, Nisha Y, Hadziomerovic AR, Prabhakar S, et al
    Comparison of Positive Predictive Values of Biparametric MRI and Multiparametric MRI-directed Transrectal US-guided Targeted Prostate Biopsy.
    Radiology. 2024;311:e231383.
    PubMed     Abstract available


  22. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
    Erratum for: Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
    Radiology. 2024;311:e249017.
    PubMed    


    May 2024
  23. LIN Y, Yilmaz EC, Belue MJ, Harmon SA, et al
    Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
    Radiology. 2024;311:e230750.
    PubMed     Abstract available


  24. PRIVE BM, Israel B, Janssen MJR, van der Leest MMG, et al
    Multiparametric MRI and (18)F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer.
    Radiology. 2024;311:e231879.
    PubMed     Abstract available


    April 2024
  25. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
    Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
    Radiology. 2024;311:e231703.
    PubMed     Abstract available


    March 2024
  26. WOODRUM DA
    Less Is More: MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer.
    Radiology. 2024;310:e240258.
    PubMed    


  27. GHAI S, Finelli A, Corr K, Lajkosz K, et al
    MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
    Radiology. 2024;310:e231473.
    PubMed     Abstract available


    December 2023
  28. MURAD V, Glicksman RM, Berlin A, Santiago A, et al
    Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.
    Radiology. 2023;309:e231407.
    PubMed     Abstract available


  29. ALABOUSI M, Ghai S, Haider MA
    MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer.
    Radiology. 2023;309:e230431.
    PubMed     Abstract available


  30. CIVELEK AC
    PSMA PET Parameters for Predicting Outcomes in Patients with Prostate Cancer.
    Radiology. 2023;309:e233023.
    PubMed    


    November 2023
  31. TAKAHASHI T
    Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials.
    Radiology. 2023;309:e231177.
    PubMed    


  32. AGUIRRE DA, Cardona Ortegon JD
    Unlocking the Benefits of Multiparametric MRI for Predicting Prostate Cancer Recurrence.
    Radiology. 2023;309:e232819.
    PubMed    


  33. LUZZAGO S, Colombo A, Mistretta FA, Alessi S, et al
    Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
    Radiology. 2023;309:e223349.
    PubMed     Abstract available


    September 2023
  34. BISCHOFF LM, Peeters JM, Weinhold L, Krausewitz P, et al
    Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI.
    Radiology. 2023;308:e230427.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.